全文获取类型
收费全文 | 6737篇 |
免费 | 388篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 210篇 |
儿科学 | 155篇 |
妇产科学 | 231篇 |
基础医学 | 953篇 |
口腔科学 | 372篇 |
临床医学 | 508篇 |
内科学 | 1523篇 |
皮肤病学 | 133篇 |
神经病学 | 513篇 |
特种医学 | 142篇 |
外科学 | 1069篇 |
综合类 | 29篇 |
预防医学 | 510篇 |
眼科学 | 146篇 |
药学 | 344篇 |
中国医学 | 34篇 |
肿瘤学 | 289篇 |
出版年
2023年 | 46篇 |
2022年 | 43篇 |
2021年 | 178篇 |
2020年 | 122篇 |
2019年 | 203篇 |
2018年 | 214篇 |
2017年 | 126篇 |
2016年 | 176篇 |
2015年 | 244篇 |
2014年 | 316篇 |
2013年 | 354篇 |
2012年 | 546篇 |
2011年 | 612篇 |
2010年 | 354篇 |
2009年 | 271篇 |
2008年 | 464篇 |
2007年 | 481篇 |
2006年 | 453篇 |
2005年 | 394篇 |
2004年 | 356篇 |
2003年 | 294篇 |
2002年 | 272篇 |
2001年 | 84篇 |
2000年 | 82篇 |
1999年 | 68篇 |
1998年 | 35篇 |
1997年 | 27篇 |
1996年 | 21篇 |
1995年 | 17篇 |
1994年 | 21篇 |
1993年 | 16篇 |
1992年 | 22篇 |
1991年 | 32篇 |
1990年 | 22篇 |
1989年 | 17篇 |
1988年 | 20篇 |
1987年 | 15篇 |
1986年 | 17篇 |
1985年 | 12篇 |
1984年 | 14篇 |
1983年 | 10篇 |
1982年 | 11篇 |
1981年 | 11篇 |
1980年 | 13篇 |
1979年 | 11篇 |
1978年 | 7篇 |
1976年 | 5篇 |
1975年 | 5篇 |
1973年 | 6篇 |
1970年 | 4篇 |
排序方式: 共有7161条查询结果,搜索用时 140 毫秒
1.
2.
Fett Mauro Sander Mariot Roberta Fogliatto Avila Eduardo Alho Clarice Sampaio Stefenon Valdir Marcos de Oliveira Camargo Flávio Anastácio 《International journal of legal medicine》2019,133(2):373-384
International Journal of Legal Medicine - It is known that Cannabis in Brazil could either originate from Paraguay or be cultivated in Brazil. While consumer markets in the North and Northeast... 相似文献
3.
4.
5.
6.
7.
8.
Marcos C. De Almeida Damian Sanchez-Quintana Robert H. Anderson 《Anatomical science international / Japanese Association of Anatomists》2020,95(3):381-386
Sunao Tawara, who was born in 1873 and died in 1952, is considered the father of modern cardiac electrophysiology. He published his monumental monograph de 相似文献
9.
Giammaria Fiorentini Camillo Aliberti Donatella Sarti Paolo Coschiera Massimo Tilli Luca Mulazzani Paolo Giordani Francesco Graziano Alfonso Marqués Gonzalez Raul García Marcos Fernando Gómez Mugnoz Maurizio Cantore Stefano Ricci Vincenzo Catalano Andrea Mambrini 《World journal of gastrointestinal oncology》2015,7(6):47-54
AIM: To investigate efficacy and safety of second-line treatment with irinotecan-loaded drug-eluting beads (DEBIRI) and cetuximab (DEBIRITUX) of unresectable colorectal liver metastases.METHODS: Patients with the following characteristics were included in the study: unresectable hepatic metastases from colorectal carcinoma (CRC-LM), progression after first line chemotherapy (any type of chemotherapeutic drug and combination was allowed), second line treatment (mandatory), which included for each patient (unregarding the KRas status) two cycles of DEBIRI (using 100-300 μm beads loaded with irinotecan at a total dose 200 mg) followed by 12 cycles of cetuximab that was administered weekly at a first dose of 400 mg/m2 and then 250 mg/m2; good performance status (0-2) and liver functionality (alanine aminotransferase and gamma-glutamyl transferase not exceeding three times the upper limit of normal, total bilirubin not exceeding 2.5 mg/mL). Data were collected retrospectively and included: tumor response (evaluated monthly for 6 mo then every 3 mo), overall response rate (ORR), KRas status, type and intensity of adverse events (G according to the Common Terminology Criteria for Adverse Events v3.0, CTCAE), overall survival (OS) and progression free survival (PFS).RESULTS: Forty consecutive cases of CRC hepatic metastases were included in the study. Median duration of DEBIRITUX was 4.4 mo (range, 4.0-6.5). Sixteen patients (40%) received the planned 2 cycles of DEBIRI and an average of 10 cetuximab cycles. ORR of the whole sample was 50%, in particular 4 patients were complete responders (10%) and 16 (40%) partial responders. The most observed side effects (G2) were: post-embolization syndrome (30%), diarrhea (25%), skin rushes (38%) and asthenia (35%). The retrospective evaluation of KRas status (24 wild type, 16 mutated) showed that the group of patients with wild type KRas had ORR significantly higher than mutant KRas. Median follow-up was 29 mo (8-48 range); median PFS was 9.8 mo and OS was 20.4 mo. Future randomized trials are required in this setting to establish a role for DEBIRITUX compared with systemic chemotherapy.CONCLUSION: DEBIRITUX seems to be efficacious after first line chemotherapy for the treatment of unresectable CRC-LM. 相似文献
10.
Evaluating Communication Skills of Geriatrics Fellows: Interrater Agreement of an Objective Structured Clinical Examination 下载免费PDF全文
Marcos Daniel Saraiva MD Maria Luiza de Melo Paulo MD Thiago Junqueira Avelino‐Silva MD Luiz Antonio Gil‐Junior MD Elina Lika Kikuchi MD Luciana Louzada Farias MD Rafael Lyra Rodrigues Alves MD Gisele Sayuri Suzuki MD Fábio Cesar Olivieri MD Valmari Cristina Aranha MSc Leonardo da Costa Lopes MD PhD Maria Cristina Guerra Passarelli MD PhD Julio Cesar Moriguti MD PhD Eduardo Ferrioli MD PhD Chao Lung Wen MD PhD Daniel Apolinário MD PhD Wilson Jacob‐Filho MD PhD 《Journal of the American Geriatrics Society》2016,64(1):206-207